Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Aggregate shares			$ 3,501,975
Shares price			1.00%
Beneficial Conversion Feature			202,305
Common Stock Issuable	1,326,700		1,326,700
Beneficial Conversion Feature Related to Incremental Shares	0		1,330,417
Selling, General And Administrative Expenses	143,113	268,955	469,356	249,854
Stock-Based Compensation Expense	1,775,262		1,775,262
Weighted Average Remaining Period				1 year 10 months 24 days
Warrants Exercise Purchase			16,983,736
Warrants Exercise Price Per Share			$ 0.25
Salary expense	87,500		262,500
Stock Options Granted	$ 1.17		$ 6.52
Series B Preferred Stock [Member]
Preferred Stock Contractual Dividends	69,840	65,271	209,520	195,813
Series C Preferred Stock [Member]
Preferred Stock Deemed Dividend	247,774		433,606
Stock Warrants [Member]
Weighted Average Fair Value			$ 1.36
Selling, General And Administrative Expenses			20,424
Stock-based compensation expense warrants			$ 493,940
Weighted Average Remaining Period			2 years